CONCORD, Calif.--(BUSINESS WIRE)--Cerus Corporation (Nasdaq: CERS) today announced that the US Food and Drug Administration (FDA) has granted approval of the INTERCEPT Blood System for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback